Investors

NuPathe is a privately-held company supported by individual and institutional investors.  NuPathe’s institutional investors include highly experienced and respected venture capitalists, including Battelle Ventures, Birchmere Ventures, Quaker BioVentures, Safeguard Scientifics (NYSE: SFE), SR One, BioAdvance, and Ben Franklin Technology Partners of Southeastern Pennsylvania.

For more information, please visit:

· Battelle Ventures
www.battelleventures.com